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Reactive oxygen species are products of cellular metabolism and assigned important roles in biomedical science as deleterious
factors in pathologies. In fact, some studies have shown that the therapeutic benefits of taking antioxidants were limited and
the potential for therapeutic intervention remains unclear. New evidences showed that ROS have some ability of intercellular
transportation. For treating allergic rhinitis, as a novel intracellular superoxide quencher, TAT-SOD applied to acupoints LI 20
instead of directly to nasal cavity can be used to test that. TTA group apply TAT-SOD cream prepared by adding purified TAT-SOD
to the vehicle cream to acupoints LI 20, while placebo group used the vehicle cream instead. TTN group applied the same TAT-SOD
cream directly to nasal cavity three times daily. Symptom scores were recorded at baseline and days 8 and 15. For the overall efficacy
rate, TTA group was 81.0%, while placebo group was 5.9% and TTN was 0%. Malondialdehyde levels decreased observably in TTA
group, and superoxide dismutase, catalase, and glutathione peroxidase levels remained basically unaffected. Enzymatic scavenging
of the intracellular superoxide at acupoints LI 20 proved to be effective in treating allergic rhinitis, while no improvement was
observed with the placebo group and TTN group.
1. Introduction
Reactive oxygen species (ROS) are products of normal cel-
lular metabolism [1, 2] and increasingly assigned important
roles in biomedical science as deleterious factors in patholo-
gies and aging [3].
ROS are known to act as second messengers in the
intracellular signaling pathways involved in activation of
proinflammatory responses [4, 5]. In addition, ROS are
widely recognized as important mediators of cell growth,
adhesion, differentiation, senescence, and apoptosis [6].
ROS participate not only in intracellular but also inter-
cellular signaling processes [7]. ROS could be released from
the mitochondria through voltage dependent anion channels
[8]. ROS has been associated with both increased and
decreased intercellular transport via plasmodesmata [9]. ROS
play important role in mitochondria dependent apoptotic
signaling via gap junctional intercellular communication
[10]. ROS have some ability of intercellular transportation.
Tamas Dolowschiak et al. indicate an important role of ROS
in horizontal epithelial cell-cell communication [11]. Wibke
Bechtel observed modulation of intercellular ROS signaling
of human tumor cells [12].
Understanding such complexity of the ROS signaling
is critically hinged on the ability to visualize and quantify
local, compartmental, and global ROS dynamics at high
selectivity, sensitivity, and spatiotemporal resolution. Many
techniques were improved to ROS imaging at levels of
intact cells, whole organs or tissues, and even live organisms
[13]. In our previous work, reproducible fluorescence lines
superimposable tomeridian lineswere revealed on the frontal
interior abdominal wall when intracellular ROS indicators
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were injected into living SD-rats tail vein, confirming the
substantial implication of ROS in meridian system [14]. A
controlled study has shown that topical application of super-
oxide dismutase (SOD) fused with the TAT peptide (TAT-
SOD), to various acupoints along the meridian lines used
in acupuncture to treat obesity, leads to significant weight
loss [15], monitoring the effects of acupoint antioxidant inter-
vention by measuring electrical potential difference along
the meridian [16].
Allergic rhinitis (AR) is a global health problem that
causes major illness and disability worldwide, including
in China [17]. There is increasing evidence that ROS is
extensively involved in multiple stages of AR pathogenesis
[18]. Theoretically, various antioxidants can be useful in AR
treatment [19]. In fact, some studies have shown that the ther-
apeutic benefits of taking antioxidants were limited and the
potential for therapeutic intervention remains unclear [20].
Furthermore, as the most primary antioxidant enzyme, SOD,
is found to fail to attenuate allergen-induced nasal congestion
in ragweed-sensitized dogs by either topical or systemic
application [21]. It is obvious that implications of ROS in
AR or effective applications of antioxidants to intervene
the processes are more complicated than what is understood.
TAT-SOD is a recombinant protein of human liver
Cu,Zn-SOD fused with TAT peptide, an 11 peptide derived
from HIV-1 transactivator of transcription protein [22],
which enables the fusion protein to be delivered cross the cell
membrane while maintaining SOD activities, making it an
intracellular superoxide quenching enzyme [23]. In the inves-
tigation on TAT-SOD’s effects on human facial skin, we acci-
dentally discovered that smearing of TAT-SOD containing
creamon certain facial acupoints (acupoints LI 20) couldmit-
igate AR symptoms such as itching, congestion, and sneezing.
What is worth noting is that topical TAT-SOD needed to
be applied to the acupoints LI 20 to be effective and appli-
cations either to nonacupoint areas or even directly to the
inflammatory nasal mucosa could not improve AR symptom.
Acupoints are locations on the body for needle stimula-
tion in acupuncture, which is believed to achieve therapeutic
effects [24]. Acupuncture is extensively used to treat AR
employing such acupoints including indispensably acupoints
LI 20. Meanwhile, there is a considerable increase in public
acceptance of acupuncture aswell as the number of rigorously
controlled trials [25]. The association between ROS and
acupuncture meridians may provide useful insight into the
mechanism of effects of the removal of the intracellular ROS
in acupoints and intercellular transportation of ROS on AR
symptoms.This study aims to validate our previous discovery
by a double-blind and placebo-controlled study, including
blood test for antioxidant status, in hope to further elucidate
complicated roles of ROS.
2. Materials and Methods
2.1. Setting. This study was performed with central enroll-
ment and allocation byHospital of FujianTraditional Chinese
Medicine University (research center). AR patients between
the ages of 18 and 43 years were recruited from October
3, 2012, to August 14, 2013. Written informed consent was
obtained from all patients before enrollment and all patients
were free towithdraw from the study at any time.TheMedical
Research Ethics Committee and Institutional Review Board
of Fujian Institute of Traditional Chinese Medicine provided
approval for this study, and all participants gave informed
consent for publication of these data.
2.2. Patients. Patients were recruited from physician offices
in the research center. These patients had an initial screening
with an allergy questionnaire and skin puncture testing to
confirm an allergic response to a perennial allergen (cat, dog,
dust mite, and indoor mold). The AR patients with a positive
skin puncture test and a total nasal symptom score of 5 or
greater (of total of 12) entered into the study. The following
patients were excluded from this study: patients with a
history or physical examination suggestive of renal, hepatic,
or cardiovascular disease; pregnant or lactatingwomen; being
treated with systemic or topical corticosteroids during the
previous 30 days; being treated with oral antihistamines or
decongestants during the previous 7 days; being treated with
immunotherapy; patients on chronic antiasthma medica-
tions; patients with nasal polyps or a significantly deviated
septum; patients with a history of an upper respiratory
infection within 14 days of study entry. No other medication
or treatment was allowed during the study period [26].
2.3. Study Schedule. AR patients underwent observation of
nasal mucosa before starting the study. At the baseline visit,
the physician recorded AR patients’ age, sex, and course
of disease and scored nasal symptoms before the morning
dose. All participants returned to the research center on day
8 for replacement of medications, scoring nasal symptoms,
and performance of nasal mucosa observation. On day 15,
all participants stopped treatment, returned medication, and
performed a final nasal mucosa observation. Adverse events
were recorded.
All participants’ venous blood samples for biochemistry
test were obtained by venepuncture with vacuum tubes on
day 0 and day 15 of the treatment period before the morning
dose.
2.4. Treatment Protocol. After the initial screening, qualified
AR patients were randomized into 1 of 3 treatment groups.
TTA groupwere instructed first to locate acupoints and apply
0.1ml of 5000U/ml TAT-SOD cream prepared by adding
purified TAT-SOD to the vehicle cream in an area of 1 cm2
to bilateral acupoint LI 20 [27], which they then conducted at
home three times daily, while placebo group used the vehicle
cream instead. TTN group applied the same TAT-SOD cream
directly to nasal cavity three times daily.
TAT-SOD was prepared by expression of recombinant
fusion protein of humanCu,Zn-SOD fused with TAT peptide
in E. coli and isolated by affinity chromatography to elec-
trophoretically pure for use. TAT-SOD cream was prepared
by the homogenization of the isolated TAT-SOD with the
vehicle cream (Johnson & Johnson, Shanghai, China) as
previously reported. TAT-SOD in the cream is remarkably
stable. SOD activity loss was less than 5.6% when TAT-SOD
was stored at room temperature for 6 months [15].
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Rhinoscopy was performed to observe the color of
inferior turbinate mucosa and to determine whether the
inferior turbinate swelled, whether the middle turbinate was
visible and whether polypoid changes existed in the middle
turbinate.
2.5. Randomization. The investigator assigned a computer-
generated random number to each participant. The investi-
gator was with no clinical involvement in the trial.
2.6. Blinding. Both the patients and researchers conducting
the study were blinded.The study intervention products were
prepared centrally by the hospital pharmacy at the Hospital
of Fujian Traditional Chinese Medicine University by inde-
pendent pharmacist not involved in the conduct of the trial.
The active product and placebo were packaged in identical
glass jars and labeled with participant code numbers. The
appearance and texture of the products were identical. This
procedure was performed by an independent pharmacist,
who was the only person aware of the codes’ meaning. The
participant code number’s meaning was concealed until all
data were analyzed.
2.7. Primary Outcome. The main outcome measures were
nasal symptoms, consisting of nasal itching, congestion,
rhinorrhea, and sneezing.The severity of each nasal symptom
recorded on a scale of 0 to 3 (0 = none, 1 = mild, 2 =
moderate, and 3 = severe), evaluated by physician on day
0, day 8, and day 15 of the treatment period according to
the principles of diagnosis and treatment of AR [28]. We
used the percentage improvement (PI) as a secondary efficacy
outcome measure, which was calculated with the following
formula: PI = (baseline scores − day 15 scores)/baseline
scores. The overall clinical effective rate on symptoms was
evaluated as deterioration (PI < 0), no improvement (0 ≤ PI
< 0.25), moderate (0.25 ≤ PI < 0.65), or marked improvement
(PI ≥ 0.65).
AR patients’ serum malondialdehyde (MDA) content
and SOD, catalase (CAT), and glutathione peroxidase (GPx)
activity were analyzed with colorimetric assay kits (Nanjing
Jiancheng Bioengineering Institute, Nanjing, China).
2.8. Statistical Analysis. The study design called for at least
45 evaluable patients, for each group at least 15 evaluable
patients. Ultimately, 56 AR patients were enrolled, with 21
in TTA group, 17 in placebo group, and 18 in TTN group.
Sample size estimations were not performed. Because of
the complex design of this pilot study, sample size was
chosen on the basis of practical considerations. Therefore,
this study was not designed to have sufficient power, and
the results of statistical testing have to be interpreted as
descriptive, explorative, and hypothesis generating rather
than as confirmatory. Data are reported as means (SEM).The
statistical analysis was performed with SPSS 15.0 (SPSS, Inc.,
Chicago, IL) and R version 2.9.0 software. Symptom scores
and blood biochemistry test results inTTAgroup andplacebo
group, TTA group, and TTN group were compared using
two-sample 𝑡-test.
3. Results
We screened 75 subjects and entered 63 subjects into the
study. 7 subjects dropped out, and 56 subjects completed the
study.The study flow is presented in Figure 1.The groupswere
matched at entry for age, sex, skin test sensitivity, and course
of disease (see Table 1). No adverse events occurred.
The mean rhinitis symptom scores at day 0, day 8, and
day 15 were shown in Table 1. After 2-week treatments, the
symptom score (total) was decreased from 6.9 to 3.0 with
TTA group, from 7.1 to 6.7 with the placebo group, and
from 7.1 to 6.9 with TTN group. Of all the three treatments,
only topical application of TAT-SOD to acupoints LI 20
significantly improved AR symptom. For the overall efficacy
rate, TTA group was 81.0% (17/21), while placebo group was
5.9% (1/17) and TTN was 0% (0/18). In rhinoscopy observa-
tion, most patients’ inferior turbinate swelled and appeared
gray in color with excessive mucus secretion before the
treatment. After 2-week treatments, 11 patients’ nasal edema
disappeared completely inTTAgroup,while no improvement
was observed with the placebo group and TTN group.
Influences of the treatments on MDA levels are shown
in Figure 2. The serum MDA levels with TTA group were
decreased from 10.8 nmol/l to 9.0 nmol/l, while those with
two other groups were increased. No significant changes in
the serum activities of SOD, CAT, and GPx were observed for
all the three groups before and after the trial, as is shown in
Figure 3.
4. Discussion
In this study, enzymatic scavenging of the intracellular super-
oxide at acupoints was demonstrated to remarkably alleviate
AR symptoms.Of all 21 patients received acupoints TAT-SOD
treatment, 33.3% (7/21) demonstrated marked improvement
and 47.6% (10/21) moderate improvement. In contrast, only
5.9% of patients in the placebo group reported moderate
improvement. Those results were also supported by our
rhinoscopy observation. The overall efficacy rate of the treat-
ment was 81.0% (17/21), which is higher than 60.0% (6/10) of
Astemizole and 67.0% (8/12) of Tefenadine [29] and compa-
rable to the most optimum results of acupuncture treatment
[30].
As shown in Table 1, the mean total nasal symptoms score
of acupoints LI 20 TAT-SOD treated patients decreased by 3.9
from baseline on day 15 by comparison with a decrease of 0.4
in the same period in placebo group and 0.2 in TTN group.
On eachnasal symptom, nasal itching and sneezing repre-
sent main characteristic symptoms besides nasal obstruction
and rhinorrhea in AR [31]. As shown in Table 1, the itching
symptom was significantly alleviated on day 8, followed by
the remarkable relief of the sneezing symptom on day 15 of
among all nasal symptoms. The sequence of the symptom
improvement is the same as treatments with mometasone
furoate nasal spray reported by Meltzer et al. [32]. However,
no improvement was observed with applying the TAT-SOD
cream directly to nasal cavity.
MDA is a marker for oxidative stress [33]. As a good
measurement of lipid peroxidation which is one of the
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75 AR subjects assessed for eligibility
12 excluded
6 did not meet inclusion criteria
4 refused to participate
1 had previous immune deficiency disease or cancer
1 did not complete surveys
63 randomized 
21 Randomized to TTA 21 randomized to placebo
4 dropped out 
because of 
noncompliance
21 eligible for analyses 17 eligible for analyses
21 randomized to TTN
3 dropped out 
because of 
noncompliance
18 eligible for analyses
Figure 1: Study flow chart.
chief mechanisms of cell damage [34], MDA level provides
another important biomarker reflecting AR progression [35].
In this study, AR patients treated with TAT-SOD cream
by topical application at acupoints instead of directly drop
into nasal cavity demonstrated a decrease in their serum
MDA level from 10.8 nmol/l to 9.0 nmol/l, while the placebo
group increased from 10.0 nmol/l to 12.2 nmol/l and the TTN
group increased from 10.8 nmol/l to 12.6 nmol/l, indicating
smearing TAT-SOD cream at acupoints reduced the nasal
epithelial oxidative damage, leading to alleviation of the
symptoms.
Histamine is a biogenic amine that plays an essential
role in controlling many physiological functions, both in
the central nervous system (CNS) and in the peripheral
nervous system (PNS) [36]. The effects of histamine have a
strong connection with the production of reactive oxygen
species [37]. The swelling of nasal mucosa is known to
be caused by histamine released from mast cells whose
activation is related to a high level intracellular superoxide
[18], which is nothing but the very substrate of TAT-SOD.
Topical TAT-SOD’s effectiveness must have been achieved via
the modulation of the intracellular superoxide level of mast
cells. Directly applying TAT-SOD to the nasal mucosa failed
to improve AR symptom possibly because TAT-SOD was
blocked by the swollen tissue from reaching mast cells. The
only explanation why TAT-SOD should be applied to distant
acupoints to take effect is that a superoxide channel exists
between the acupoints and mast cells. It is true that TAT-
SODdid not influence thewhole system since serum contents
of antioxidant enzymes remained unchanged, as is shown in
Figure 3. Our results indicate that the effect of smearing TAT-
SOD cream at acupoints did not work to boost the general
serum antioxidant capability of the patients but to scavenge
the intracellular superoxide locally at the acupoints which
must have been somehow connected to nasal epithelium,
possibly through a meridian line, leading to a lower level of
nasal epithelial damage. In acupuncture, it is known that a
channel exists between acupoints and the targeted tissue or
organ.
As is shown by our previous work [14], these channels
may be the alignment of cells with a high content of
superoxide, it is possibly a novel channel for superoxide
transporting and disposal between acupoints and the action
target of acupuncture, as is in this case a channel between LI
20 and nasal epithelium.
As is illustrated in Figure 4, a channel is hypothesized
through which superoxide can travel from mast cells to acu-
points because of the electric potential change due to intra-
cellular superoxide removal in the acupoints. The channel
could well be the acupuncture meridian which anatomically
coincides with connective tissues which also connects tomast
cells [38].
Apparently, it is a formidable work to prove and charac-
terize the novel superoxide channels, but what is immediately
possible is a real double-blind and placebo-control study of
efficacy of acupuncture which is extremely likely to interfere
with that novel channels. Hopefully, acupuncture with TAT-
SOD but not needle can help accelerate the formation of
scientific consensus.One of themajor difficulties with clinical
study of acupuncture’s efficacy is its inevitable placebo effects
when a needle is inserted into the body [39], which may
contribute to the minor advantages in the efficacy rates
reported over our TAT-SOD acupoints treatment.
The enzymatic scavenging of the intracellular superoxide
at acupoints in the clinical setting has been demonstrated
to achieve an efficacy in treating AR patients comparable
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Table 1: Characteristics of subjects in TTA, placebo, and TTN groups, mean (SEM).
Parameter/treatment TTA Placebo TTN 𝑝 value∗ 𝑝 value∗∗
Baseline assessment
Number 21 17 18 NA NA
Age (y), mean (SEM) 30.0 (10.3) 30.6 (12.4) 30.2 (11.2) 0.43 0.95
Sex (M/F) 8/13 7/10 7/11 NA NA
Skin test (number of positive patients)
Dust mite 18 15 15 NA NA
Cat 0 0 0 NA NA
Dog 0 0 0 NA NA
Mold 3 2 3 NA NA
Dust mite wheal (mm), mean (SEM) 9.0 (1.2) 9.4 (0.6) 9.2 (0.7) 0.18 0.54
Course of disease (y), mean (SEM) 6.5 (4.8) 7.4 (5.1) 7.5 (3.2) 0.58 0.46
Symptom score, mean (SEM)
Stuffiness 1.8 (0.6) 1.9 (0.6) 1.8 (0.6) 0.71 0.99
Sneezing 1.4 (0.6) 1.4 (0.6) 1.5 (0.8) 0.89 0.66
Rhinorrhea 1.8 (0.8) 1.9 (0.8) 1.9 (0.6) 0.78 0.67
Itching 1.9 (0.8) 1.9 (0.9) 1.9 (0.8) 0.93 0.99
Total 6.9 (1.8) 7.1 (1.8) 7.1 (1.7) 0.87 0.72
Day 8
Symptom score, mean (SEM)
Stuffiness 1.3 (0.6) 1.5 (0.5) 1.6 (0.6) 0.44 0.13
Sneezing 1.2 (0.6) 1.2 (0.5) 1.4 (0.6) 0.93 0.31
Rhinorrhea 1.3 (0.6) 1.8 (1.0) 1.9 (0.6) 0.09 <0.01
Itching 1.3 (0.6) 1.9 (0.6) 1.9 (0.6) <0.001 <0.001
Total 5.1 (1.3) 6.4 (1.2) 6.8 (1.1) <0.01 <0.001
Day 15
Symptom score, mean (SEM)
Stuffiness 0.8 (0.6) 1.7 (0.6) 1.6 (0.7) <0.001 <0.001
Sneezing 0.4 (0.6) 1.4 (0.8) 1.4 (0.6) <0.001 <0.001
Rhinorrhea 1.0 (0.7) 1.5 (0.6) 1.9 (0.6) 0.01 <0.001
Itching 0.8 (0.6) 2.1 (0.7) 2.0 (0.5) <0.001 <0.001
Total 3.0 (1.7) 6.7 (1.2) 6.9 (1.1) <0.001 <0.001
Therapeutic response, number (percentage)
Deterioration 1 (4.8%) 2 (11.7%) 3 (16.7%) NA NA
None 3 (14.3%) 14 (82.4%) 15 (83.3%) NA NA
Moderate 10 (47.6%) 1 (5.9%) 0 (0%) NA NA
Marked 7 (33.3%) 0 (0%) 0 (0%) NA NA
NA, not applicable.
∗Two-sample 𝑡-test comparing treatment means of TTA versus placebo.
∗∗Two-sample 𝑡-test comparing treatment means of TTA versus TTN.
to acupuncture, as is evaluated by both clinical measure-
ments and serum biomarkers, proving that our hypothesis
that enzymatic scavenging of intracellular superoxide could
generate acupuncture-like efficacy is correct. Much more
investigation is necessary before a novel regiment of TAT-
SOD treatment of AR can be established; the current results
clearly suggest a great possibility of replacing a mysterious
and cumbersome treatment of acupuncture with an intracel-
lular superoxide scavenging treatment at acupoints no more
difficult than applying skin care products.
What is more significant about the confirmation of
our hypothesis of this work is that it is true that removal
of intracellular superoxide is a key process related to the
efficacy of acupuncture treatment. Acupuncture has been
proved to be effective, but other than scientifically intangible
Qi concept and mysterious theory in Traditional Chinese
Medicine (TCM), there is no understanding about what
exactly happens immediately after a needle is inserted into
acupoints in the modern scientific terms, not to mention
the whole mechanism of the treatment. On the contrary,
it is a matter of fact that TAT-SOD can do nothing but
to be delivered into cells to remove superoxide there once
it is applied topically to acupoints. Enzymatic removal of
intracellular superoxide has generated remarkably similar
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Day 15
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Figure 2: Allergic rhinitis patients’ serum malondialdehyde (MDA) content were analyzed. Bars represent the mean ± standard error of the
mean. Asterisks denote 𝑝 < 0.05 considered significant compared to TTA group.
TTA Placebo TTN
CAT (U/ml)
TTA Placebo TTN
GPx (U/ml)
TTA Placebo TTN
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Figure 3: Allergic rhinitis patients’ serum SOD, catalase (CAT), and glutathione peroxidase (GPx) activity were analyzed. Bars represent the
mean ± standard error of the mean. No significant changes in the serum activities of SOD, CAT, and GPx were observed for all the three
groups.
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Figure 4: Model of scavenging the intracellular superoxide locally at the acupoints leading to a lower level of nasal epithelial damage through
a meridian line. In allergic rhinitis, house dust exposure induces nasal epithelium to produce ROS, which can challenge mast cells to release
the proinflammatory mediators, including histamine. Histamine plays a crucial role in the development of nasal blockage, pruritus, sneezing,
and rhinorrhea. ROS could control excitability of connective tissues through redox modulation of membrane generating ROS and vice versa.
ROS produced in this compartment play a critical role in inflammatory signaling in AR. Meridian lines connecting acupoints and nasal
epithelium must be a channel implicated with ROS. Scavenging the intracellular ROS locally at the acupoint leads to lower level of nasal
epithelial damage through a meridian line.
efficacy in treating AR, suggesting that acupuncture may
work on the same mechanism of intracellular removal at
acupoints. What is different with acupuncture may be that it
removes intracellular superoxide at acupoints by puncturing
cells containing superoxide and cause a leakage rather than
enzymatic scavenging inside the cells. As is shown by our
previous work [14], meridian lines may be the alignment of
cells with a high content of superoxide, it is possibly a novel
channel for superoxide transporting and disposal between
acupoints and the action target of acupuncture, as is in this
case a channel between LI 20 and nasal epithelium. It will
be a formidable task to answer questions such as where
those superoxide anions originate, how they are transported
intercellularly along the meridian line, and why they are
distributed along the line; nevertheless, the association of
meridian systemwith intracellular superoxide as reconfirmed
by this study provides promising new clues to not only the
elucidation of themechanismof effective but overwhelmingly
suspected acupuncture treatment but also the discovery of an
anatomically adelomorphic system in mammals.
If the intracellular superoxide scavenging at acupoints can
be confirmed as a process in the mechanism of acupuncture,
enzymatic action by TAT-SOD can provide a convenient
solution to the dilemma in the clinical study of acupuncture
treatment. The scientific investigation on acupuncture has
been suffering from a lack of a reliable placebo in clinical
study [39], which fatally jeopardizes the scientific quality
of almost all the clinical works [40], contributing to the
awkward status of acupuncture not much better than necro-
mantic superstition in spite of being a treatment with the
longest history and popularity in humanmedical history and
enormous quantity of researches. TAT-SOD may become a
critical tool to upgrade the scientific quality of acupunc-
ture research and accelerate it when further investigations
on more conditions confirm the feasibility of substituting
acupuncture with TAT-SOD treatment.
5. Conclusions
In this study, a novel acupoint therapy of the intracellular
superoxide scavenging byTAT-SODat acupointswas demon-
strated to significantly alleviate the symptoms and signs
of AR with an overall efficacy comparable to acupuncture,
while no improvement was observed with applying the TAT-
SOD cream directly to nasal cavity. TAT-SOD treatment
may provide a novel and convenient alternative to acupunc-
ture. Moreover, the removal of intracellular superoxide at
acupuncture may be an important process in the mechanism
of acupuncture.
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